Anavex Life Sciences Corp (AVXL)

[georgesk]

I have slightly higher odds for AA but otherwise agree with this assessment.

I'm starting to think that we'll partner up for that P3. We can't keep going at this pace.

All in all, when you take the plethora of pre-clinical and clinical data we currently have, I'm pretty confident that Blarcamesine is therapteuric. We just need that confirmatory trial to settle this once and for all, no buts and ifs. And no more dose dependency, just 2 arms, active and placebo.

With that said, this will most probably be my last post until the next major news we get (Rett TLR most probably). Thanks everyone for the productive discussions.